Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if patients who take YM598 in addition to mitoxantrone and prednisone (standard therapy) experience improvement in the pain associated with prostate cancer me...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Astellas Pharma Inc
Collaborators
NCT06190899 · mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, and more
NCT07225946 · Prostatic Neoplasms, Castration-Resistant
NCT04868604 · Prostatic Neoplasms, Castration-Resistant
NCT06751329 · Ovarian Neoplasms, Prostatic Neoplasms, and more
NCT00756665 · Prostatic Neoplasms
Alaska Clinical Research Center, LLC
Anchorage, Alaska
San Bernardino Urological Associates
San Bernardino, California
Western Clinical Research, Inc.
Torrance, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions